These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7302972)

  • 41. Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes.
    Omri A; Agnew BJ; Patel GB
    Int J Toxicol; 2003; 22(1):9-23. PubMed ID: 12573945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of formaldehyde in the rat and dog following oral exposure.
    Johannsen FR; Levinskas GJ; Tegeris AS
    Toxicol Lett; 1986 Jan; 30(1):1-6. PubMed ID: 3952767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. l-Bunolol and propranolol: oral and intravenous beta-adrenoceptor blocking activity in rats compared to dogs and humans.
    Kaplan HR; Commarato MA; Lattime EC
    J Pharm Sci; 1978 Jan; 67(1):132-3. PubMed ID: 22739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The toxicity of bencyclane and papaverine in rats. A comparative study over 45 days].
    Lehoczky Z
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1394+. PubMed ID: 5536651
    [No Abstract]   [Full Text] [Related]  

  • 45. [Toxicological studies on a new cephamycin, MT-141, IV. Its acute toxicity in beagle dogs].
    Kurebe M; Yokota M; Kawaoto H; Niizato T; Hayasaka H; Seki M
    Jpn J Antibiot; 1984 Jun; 37(6):1070-99. PubMed ID: 6436546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chronic intravenous toxicity studies of potassium clavulanate and BRL28500 in dogs].
    Koyu A; Kurakata Y; Koyanagi J; Nishioka Y; Koshima Y; Nagata R; Onishi M; Kobayashi K; Sato M; Katayama T
    Jpn J Antibiot; 1986 Nov; 39(11):2831-62. PubMed ID: 3820567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Cardiovascular Effect of Single Injection and Toxicologic Effects of Repetitive 2-Week Intravenous Administration of Activin A/BMP-2 Chimera in Beagle Dog.
    Lee JH; Choe S; Han S
    Cardiovasc Toxicol; 2018 Feb; 18(1):76-83. PubMed ID: 28612305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs.
    Yaksh TL; Grafe MR; Malkmus S; Rathbun ML; Eisenach JC
    Anesthesiology; 1995 Feb; 82(2):412-27. PubMed ID: 7856900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of intravenous administration of 10% travamulsion fat emulsion to beagle dogs for 91 consecutive days.
    Izzo RS; Leissing N; Woods E; Remis W; Napoli M; Kroes R; Larcker S
    JPEN J Parenter Enteral Nutr; 1983; 7(3):257-65. PubMed ID: 6683333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical toxicology of pirmenol hydrochloride.
    Martin RA; de la Iglesia FA
    Am J Cardiol; 1987 Jun; 59(16):10H-14H. PubMed ID: 3591709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys.
    Kuhlmann O; Paehler A; Weick I; Funk C; Pantze M; Zell M; Timm U
    Xenobiotica; 2010 Dec; 40(12):840-52. PubMed ID: 20868265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute, subacute and chronic oral toxicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in beagle dogs.
    Tabata H; Matsuzawa T; Hanada T; Ishikawa A; Yamada M; Ozaki H; Izumisawa N; Barker MH; Cox RA; Buist DP
    Arzneimittelforschung; 1995 Jul; 45(7):760-6. PubMed ID: 8573218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the affinity and selectivity of tiquizium bromide (HSR-902), a novel spasmolytic agent, for muscarinic receptors.
    Oshita M; Ohashi T; Morikawa K; Kato H; Ito Y; Muramatsu I
    Jpn J Pharmacol; 1987 Jun; 44(2):222-4. PubMed ID: 3656779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological properties of 3-(p-chlorobenzyl) quinolizidine tartarate (QB-1), a new oxytocic.
    Nagashima R; Takano N; Tamura M; Shioya A
    Jpn J Pharmacol; 1966 Dec; 16(4):353-67. PubMed ID: 5298711
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic intravenous toxicity of the new antibiotic cefpirome in monkeys.
    Horstmann G; Engelbart K
    Arzneimittelforschung; 1990 Nov; 40(11):1250-9. PubMed ID: 1982210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Subacute toxicity test of cefoperazone in beagle dogs with the intravenous administration for 3 months (author's transl)].
    Yoneda T; Masatani H; Shibata T; Kawamura Y; Sato S; Iwasaki S; Takimoto Y; Nagasawa M; Takai A
    Jpn J Antibiot; 1980 Oct; 33(10):1028-55. PubMed ID: 6451720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute and sub-chronic toxicity studies of Danshen injection in Sprague-Dawley rats.
    Wang M; Liu J; Zhou B; Xu R; Tao L; Ji M; Zhu L; Jiang J; Shen J; Gui X; Gu L; Bai W; Sun W; Cheng J
    J Ethnopharmacol; 2012 May; 141(1):96-103. PubMed ID: 22343168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
    Han J; Shin HC; Kim JC; Kim B
    Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effects of DF 594, a new antispasmodic agent, on intestinal motility in the dog.
    De Ponti F; Ambrosoli L; Borsa M; D'Angelo L; Frigo GM; Crema A
    Pharmacology; 1989; 38(6):374-80. PubMed ID: 2813498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of piperidine and its related substances on blood vessels.
    Aisaka K; Hattori Y; Ishihara T; Morita M; Kasé Y; Miyata T
    Jpn J Pharmacol; 1985 Apr; 37(4):345-53. PubMed ID: 4010086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.